Patient online self-reporting of toxicity symptoms during chemotherapy

Ethan Basch, Dorothy Dulko, David Artz, Kevin S. Scher, Paul Sabbatini, M. Max Hensley, Nandita Mitra, John Speakman, Mary S. McCabe, Deborah Schrag

Journal of Clinical Oncology · 2005 · 11 citations · 0 references

Concepts

Abstract

6025 Background: Assessing symptoms of treatment toxicity is standard practice during routine care and clinical trials. Currently, clinicians gather symptom information via complex and often inefficient mechanisms. There is growing interest in patient reported outcomes, but it remains unknown if patients can be engaged to report their own symptoms during chemotherapy, or whether practitioners will view this information as reliable towards management decisions or regulatory reporting. Methods: The NCI’s Common Terminology Criteria for Adverse Events (CTCAE) schema for 7 common symptoms was adapted into a web-based patient-reporting system, accessible from computers in outpatient clinics and from home computers. 80 outpatients with gynecologic malignancies beginning standard chemotherapy regimens were enrolled. During an 8-week observation period, participants were encouraged to login and report symptoms at each follow-up visit, or alternatively to access the system from home. Severe toxicities entered into the system (grade 3–4) triggered emails to the primary clinical team. Results: All 80 patients completed an initial login. At each subsequent appointment, most enrollees (80–85%) reported symptoms using the online system, with a mean of 3 visits per patient (range 1–6). 68/80 (85%) logged in at more than two-thirds of appointments. 60/80 (75%) logged in at least once from home, with a mean of 9 logins among home users versus 3 among non-home users. Utilization was associated with prior Internet experience (p=0.002) but not with age, cancer type, ECOG score, income, or education level. Forty-two severe toxicities entered from home prompted 7 telephone interventions and 3 new clinic visits. 96% of patients found the system useful, easy to use, and would recommend it to others. 8/9 (89%) of participating clinicians felt STAR reports reflected patients’ clinical status, and based clinical decisions on these data. Conclusion: Patients are capable of reporting symptoms experienced during chemotherapy via the web, and clinicians view these as a potentially valuable source of toxicity data. Assessment in the clinical trial setting and comparison of patient versus clinician symptom reporting will be performed in a separate study. No significant financial relationships to disclose.